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Abstract: 
 
Introduction: We sought to investigate the frequency of microbleed (MB) development 
following intracerebral hemorrhage (ICH) in a predominantly African-American population and 
to identify predictors of new MB formation.  
Methods: The DECIPHER study was a prospective, longitudinal, MR-based cohort study 
designed to evaluate racial/ethnic differences in risk factors for MBs and to evaluate the 
prognostic impact of MBs in this ICH population. We evaluated new MB formation in 2 time 
periods: from baseline to 30 days and from 30 days to year 1.  
Results: Of 200 subjects enrolled in DECIPHER, 84 had MRIs at all required timepoints to meet 
criteria for this analysis. In the baseline to day 30 analysis, 11 (13.1%) had new MBs, compared 
to 25 (29.8%) in the day 30 to year 1 analysis. Logistic regression analysis demonstrated that 
baseline number of MBs (OR 1.05 [95% CI 1.01, 1.08], p=0.01) was associated with new MB 
formation at 30 days. A logistic regression model predicting new MB at 1 year included baseline 
number of MBs (OR 1.05 [1.00, 1.11], p=0.046), baseline age (OR 1.05 [1.00, 1.10], p=0.04) 
and WMD disease score (OR 1.18 [0.96, 1.45]. p=0.115). Overall 28 of 84 (33.3%) ICH subjects 
formed new MBs at some point in the first year post-ICH.  
Conclusions: We found that one-third of ICH subjects in this cohort surviving one year 
developed new MBs, which suggests a dynamic and rapidly progressive vasculopathy. Future 
studies are needed to examine the impact of new MB formation on patient outcomes. 
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Introduction: 
Cerebral microbleeds (MBs) are small, chronic, asymptomatic, perivascular hemorrhages that 
appear as dark round areas of signal loss detected on T2*-weighted magnetic resonance images. 
MBs are increasingly recognized as markers for a hemorrhage-prone vasculopathy(1) and have 
been reported in up to 35% of community-dwelling elderly,(2) 30% of ischemic stroke patients, 
and 60% of intracerebral hemorrhage (ICH) patients.(3) MBs have been associated with 
increased bleeding risk in ischemic stroke(4) and ICH populations,(5, 6) and have also been 
associated with cognitive impairment.(7) 
 
Evidence suggests that MB formation is a highly dynamic process, with new MBs forming 
shortly after ischemic stroke,(8) carotid artery stenting,(9) thrombolysis,(10) and cardiac valve 
surgery,(11) among other conditions; however, few studies have evaluated the rate and time 
course of new MB development prospectively following ICH,(5, 6) particularly in the first 
month. Furthermore, few studies have assessed MBs in the African-American population with 
predominantly hypertensive ICHs.(12) We therefore sought to investigate the frequency of rapid 
MB development and to identify predictors of new MB formation in this population. 
 
Methods: 
The Differences in the Imaging of Primary Hemorrhage Based on Ethnicity or Race 
(DECIPHER) study was a prospective, longitudinal, MR-based cohort study designed to evaluate 
racial/ethnic differences in risk factors for MBs and to evaluate the prognostic impact of MBs in 
underserved, predominantly African-American subjects with ICH. Subjects were recruited from 
five Washington, DC hospitals from 2007-2012. For inclusion in the study, subjects had to be 18 
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years of age or older and diagnosed with a primary ICH. Subjects who were pregnant, unable to 
undergo an MRI, or diagnosed with a CNS tumor, active infectious or inflammatory process such 
as encephalitis, AVM, or aneurysm were excluded. Subjects were also excluded if they had CNS 
trauma within the previous two weeks, a craniotomy, or an INR>3. Baseline demographics, 
vascular risk factors, medications, laboratory data, and neurological assessments were obtained 
for each subject. Follow-up MRIs were performed at day 30 and year 1 following initial ICH. 
 
The general imaging analysis performed in the DECIPHER study has been described 
previously.(13) For inclusion in the present study subjects had to have usable gradient recalled 
echo (GRE) images (1.5 or 3T; repetition time, 46 to 825 ms; echo time, 12 to 30.5 ms; flip 
angle, 20 to 40 degrees; and slice thickness, 3.5 to 7 mm) at baseline, 30 days from onset, and 1 
year from onset. Figure 1 demonstrates a flow chart for subject inclusion for the present study in 
the setting of the larger DECIPHER cohort. Sequence parameters were provided to each of the 
sites to optimize standardization of the gradient echo protocol across hospitals; in addition, the 
vast majority of day 30 and year 1 images were performed on a single scanner. We evaluated 
new MB formation in two time periods: from baseline to day 30 and from day 30 to year 1.  Day 
30 and year 1 images were co-registered to the baseline images using MIPAV (Medical Image 
Processing, Analysis, and Visualization, http://mipav.cit.nih.gov/). Blinding of imaging time-
point was not possible because of the appearance of the primary ICH, which has distinct 
characteristics at each timepoint. Hypointensities in the sulci consistent with vessels and 
symmetric hypointensities in the basal nuclei thought to represent calcification were not 
considered MBs. Hypointensities closely adjacent to or contiguous with the primary ICH were 
not considered MBs. MB presence and location at all three timepoints were determined by 
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consensus review by two stroke neurologists with imaging expertise. White matter disease 
(WMD) score was determined via a modified Fazekas method(14) with a score of 0 to 3 on each 
side for both the periventricular and deep white matter regions (maximum score of 12). The 
covariates of hyperlipidemia, diabetes, prior TIA or stroke, history of antithrombotic use, 
smoking history, atrial fibrillation coronary artery disease, and statin use were obtained at 
baseline via history. Mean arterial pressure in mmHg was obtained at baseline, 30 days, and 1 
year. ApoE status was stratified by ε3/ε3 vs. ε2/-- or ε4/--. Socioeconomic status was 
dichotomized by middle to upper status vs. lower to lower-middle status using a combination of 
occupation and education to generate the Hollingshead two factor index of social position.(15) 
 
Statistical Methods 
Univariate analyses were performed for both time intervals using chi-square, Fisher’s exact, 
Student’s t, or Wilcoxon rank sum tests where appropriate. Logistic regression analysis was 
performed for both time periods with new MB formation as the outcome variable. Variables that 
were borderline statistically significant (p ≤ 0.10) in the univariate analyses were considered for 
inclusion as predictors in the logistic regression model. Statistical analyses were performed with 
SAS version 9.3 (SAS institute, Cary NC). 
 
IRB approval/general statement 
The IRBs of the five study hospitals approved the DECIPHER study; Georgetown University 
served as the IRB of record. 
 
Results: 
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Of the 200 subjects enrolled in DECIPHER, 84 subjects had MRIs at all three timepoints and 
thus met criteria for this subset analysis; 42.9% were women and 78.6% were African-American. 
The mean age was 58.0 years (SD 13.6). The median baseline NIHSS score was 4 (IQR 2-10). 
The median ICH volume was 11.4 mL (IQR: 4.9-29.7) and mean volume was 18.2 mL (SD 
17.2). ICH location was deep in 72.6% and 81% of subjects had a history of hypertension. 
 
Baseline – day 30 analysis 
Of 84 subjects, 11 (13.1%) developed new MBs by day 30. The univariate analysis 
dichotomizing subjects into new MBs and no new MBs is shown in Table 1. Aside from the 
number of baseline MBs and prior TIA/stroke, there were no significant differences between 
groups in terms of demographics, vascular risk factors, or ICH characteristics. There were no 
significant differences between the groups with regard to apoE status, smoking, atrial fibrillation, 
hyperlipidemia, or coronary artery disease (data not shown). 
 
Multivariable analysis  
The predictors of new MB formation considered for the model were age, baseline number of 
MBs, diabetes, and prior TIA/stroke. Simple logistic regression analysis demonstrated that for a 
one unit increase in number of baseline MBs, the odds of having a new MB at day 30 increased 
by 5% (OR 1.05 [95% CI 1.01, 1.08], p=0.01). 
 
Day 30 – year 1 analysis 
Of 84 subjects in this analysis, 25 (29.8%) developed new MBs between day 30 and year 1. The 
univariate analysis dichotomizing subjects into new MBs and no new MBs is shown in Table 2. 
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Subjects developing new MBs at 1 year were older, had higher WMD scores, more MBs at 30 
days, higher mean arterial pressures (MAPs) at 1 year, and were more likely to have had a prior 
TIA/stroke. There was a trend toward more diabetes and lower socioeconomic status in the new 
MBs group. Again, there were no significant differences between the groups with regard to apoE 
status, smoking, atrial fibrillation, hyperlipidemia, or coronary artery disease (data not shown). 
An example of new MB formation at 1 year is shown in Figure 2. 
 
Multivariable analysis  
The predictors of new MB formation considered for the model were age, WMD score, baseline 
number of MBs, MAP, diabetes, prior TIA/stroke, and socioeconomic status. Our final logistic 
regression model included age, baseline number of MBs, and WMD. This model demonstrated 
that for a one unit increase in the number of MBs, the odds of having a new MB at year 1 
increased by 5% (OR 1.05 [95% CI 1.00, 1.11], p=0.05). Similarly, a one year increase in age 
increased the odds of having a new MB at year 1 by 5% (OR 1.05 [1.00, 1.10], p=0.04). 
Although the association between WMD and new MBs at year 1 did not meet statistical 
significance, we included it in the model; in this model, a one unit higher WMD score increased 
the odds of having a new MB at year 1 by 18% (OR 1.18 [0.96, 1.45], p=0.12). 
 
Overall 28 of 84 (33.3%) ICH subjects formed new MBs at some point in the first year post-ICH. 
In a subset analysis of subjects with only 3T MRI GRE images at all three time points, 12 of 39 
(30.8%) formed new MBs at any time point. The location of MBs at baseline stratified by index 
ICH location is shown in Table 3. Index cerebellar and brainstem ICHs were categorized as 
deep. There were 43 subjects (51.2%) with MBs at baseline; there were no significant differences 
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between the deep and lobar ICHs with regard to MB location (Fisher exact=0.33). Table 4 shows 
the location of incident MBs stratified by index ICH location. Most incident MB formation in the 
first 30 days occurred in the lobar region. We did not observe a clear pattern of location of 
incident MB formation based on index ICH location. 
 
Discussion: 
In this predominantly hypertensive African American population, we found that one-third of ICH 
subjects who survived one year developed new MBs and that baseline number of MBs and age 
are independently associated with new MB formation. Our study also supports previous studies 
demonstrating that new MB formation is associated with higher WMD scores. Our study 
uniquely quantifies the relatively rapid rate of MB development over the first year following a 
primary ICH in a systematic and prospective study. 
 
Prospective studies of new MB formation in ICH subjects are relatively sparse. Investigators in 
Boston evaluated new MB formation in a predominantly white population with lobar ICH and 
found that 17 of 34 (50%) subjects undergoing follow-up imaging at approximately 16 months 
had new MBs.(5) Investigators in Korea found that 19 of 63 (30%) subjects undergoing repeat 
imaging at a median of 23 months developed new MBs.(6) Neither of these studies evaluated 
MB formation shortly after ICH. Thirteen percent of subjects in our study developed new MBs 
by day 30, which suggests that some subjects may be at particularly high risk for appreciable 
progression of vasculopathy in the period immediately following ICH. 
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Histopathologic work has demonstrated that MBs noted on GRE sequences represent 
hemosiderin-laden macrophages adjacent to small vessels.(16) While small vessel angiopathies 
due to hypertensive disease or cerebral amyloid angiopathy are thought to play critical roles, the 
mechanisms of MB formation and the triggering factors are not entirely clear. Extravasation of 
blood due to blood-brain barrier disruption may be due to several inter-related factors, including 
endothelial dysfunction, active inflammation, and loss of autoregulation, all of which are 
common in the immediate period following ICH. A large cohort study has found that risk factors 
for MB formation include advancing age, cardiovascular risk factors for deep MBs, and 
apolipoprotein E4 for strictly lobar MBs.(2) Baseline MBs,(8) African-American race(12) and 
chronic kidney disease(17) have also been associated with MB formation. A recent longitudinal 
study has also found that blood pressure variability in patients with recent ischemic stroke was 
associated with MB progression.(18) 
 
In this study, we found that WMD score may be associated with new MB formation at 1 year in 
ICH subjects, though this did not reach statistical significance. WMD has previously been 
associated with new MB formation following ischemic stroke(8) and has also been associated 
with new DWI lesion formation in ICH subjects.(19, 20) Emerging evidence suggests that a 
widespread vasculopathic process accompanies the peri-ICH period, and several groups have 
reported DWI-positive lesions shortly after ICH(13, 19-23) and even one year after the index 
hemorrhage.(24) A dynamic interplay between new ischemic lesions and MBs(25) may be 
occurring. One possible explanation for differing lesion types is that the peri-ICH environment 
leads to very fragile vessels in which relative hypotension may predispose to an ischemic event 
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and relative hypertension to a microhemorrhage in the setting of compromised microstructural 
integrity.(26)   
 
The present work is the largest prospective study of MBs in a predominantly African-American 
cohort and is the first study to evaluate new MB formation in the first month following ICH. This 
study builds upon the work demonstrating rapid new MB formation following ischemic stroke by 
extending similar findings to ICH. Additional strengths of this work are co-registration of images 
to prevent misclassification and standardized imaging timepoints. There are also several 
limitations to this study. DECIPHER was not designed to be a population-based study and the 
results of this analysis might not be generalizable to the population as a whole, though it 
provides novel and important data in an underserved population. The sample size of subjects 
who formed new MBs was somewhat small, particularly in the baseline to day 30 analysis. The 
sample size also limited the number of predictor variables in the multivariable model.(27) 
Inclusion of 3T and 1.5T MRI increases the possibility of bias as higher field strength is 
associated with improved MB detection.(28) We also did not perform blinded individual reads of 
the images. We instead relied on a consensus review of the co-registered images together to 
reduce ‘overcall’ of new MB formation. Finally, ascertainment bias is a concern because 
inclusion in the study required subjects being well enough to undergo an MRI without significant 
motion artifact at three different time points. 
 
Rapid MB formation following ICH suggests an ongoing dynamic and rapidly progressive 
vasculopathy in these subjects. Further prospective work with larger samples will more fully 
evaluate risk factors for new MB formation and examine the impact of new MB formation and 
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location on patient outcomes. Much additional work is also needed to identify interventions to 
arrest the vasculopathic process. 
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Table 1: Baseline – day 30 characteristics 
 New MBs  
(n=11) 
No new MBs  
(n=73) 
p-value 
Age (mean, SD) 63.8 (11.5) 57.1 (13.7) 0.10 
Female 5 (45%) 31 (42%) 0.99 
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Race (black) 7 (64%) 59 (81%) 0.24 
WMD score, 
median (IQR) 
8 (6-10) 6 (4-10) 0.15 
ICH volume, mL 
(MRI) 
5.4 (3.3-31.0) 11.8 (5.5-29.2) 0.13 
Baseline no. of 
MBs, median (IQR) 
17 (3-61) 0 (0-5) 0.002 
MAP at outcome 
timepoint (mmHg, 
SD) 
104 (14) 99 (13.6) 0.38 
ICH location 
(baseline MRI) 
    0.48 
   Lobar 4 (36%) 19 (26%)   
   Deep 7 (64%) 54 (74%)   
Diabetes 4 (36%) 11 (15%) 0.10 
Prior TIA/stroke 7 (64%) 15 (21%) 0.01 
SES (middle or 
higher) 
6 (55%) 38* (53%) 0.91 
Antithrombotic at 
baseline 
4 (36%) 19 (26%) 0.48 
Statin use at 
baseline 
3 (27%) 10 (14%) 0.36 
*One subject missing SES data  
 
 
 
 
Table 2: Day 30 – year 1 characteristics 
 New MBs  
(n=25) 
No new MBs 
(n=59) 
p-value 
Age (mean, SD) 65.1 (13.3) 54.9 (12.6) 0.002 
Female 10 (40%) 26 (44%) 0.73 
Race (black) 21 (84%) 45 (76%) 0.43 
WMD score, 
median (IQR) 
8 (7-10) 5 (4-8) <0.001 
ICH volume, mL 7.9 (3.4-22.5) 11.8 (5.2-33.5) 0.23 
Baseline no. of 
MBs, median (IQR) 
8 (0-18) 0 (0-2) 0.001 
MAP at outcome 
timepoint (mmHg, 
SD) 
113 (23) 100 (18) 0.04 
ICH location 
(baseline MRI) 
    0.54 
   Lobar 8 (32%) 15 (25%)   
   Deep 17 (68%) 44 (75%)   
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Diabetes 8 (32%) 7 (12%) 0.06 
Prior TIA/stroke 11 (44%) 11 (19%) 0.02 
SES (middle or 
higher) 
9* (38%) 35 (59%) 0.07 
Antithrombotic at 
day 30 
9 (36%) 14 (24%) 0.25 
Statin use at day 30 3 (12%) 10 (17%) 0.75 
* One subject missing SES data 
 
 
 
Table 3: Microbleed location at baseline stratified by ICH location 
 No MBs at 
baseline 
Only deep MBs Only lobar MBs Deep and lobar 
MBs 
Deep ICH  27 (44.3%) 8 (13.1%) 6 (9.8%) 20 (32.8%) 
Lobar ICH 14 (60.9%) 0 2 (8.7%) 7 (30.4%) 
Note: ‘Deep’ includes cerebellum and brainstem 
 
 
 
Table 4: Location of new microbleed formation in relation to primary ICH location 
 New deep MBs New lobar MBs New deep and lobar MBs 
Day 30    
     Deep ICH 0 7 0 
     Lobar ICH 1 2 1 
1-year    
     Deep ICH 5 5 7 
     Lobar ICH 4 3 1 
Note: ‘Deep’ includes cerebellum and brainstem 
 
 
Figure 1: Flowchart demonstrating exclusions from the overall DECIPHER cohort  
 
 
 
Figure 2: Axial gradient recalled echo images from day 30 and year 1 demonstrating new 
microbleed formation at year 1. 
 
Fig.1 Flowchart demonstrating exclusions from the overall DECIPHER cohort. 
 
 
  
Fig. 2 Axial gradient recalled echo images from day 30 and year 1 demonstrating new 
microbleed formation at year 1. 
 
 
